---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-009489"
form_type: "8-K"
ticker: "CLB"
cik: "0001958086"
company_name: "Core Laboratories Inc. /DE/"
filed_at: "2024-01-31T23:59:59+00:00"
generated_at: "2026-06-06T14:12:45.282141+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Core Lab Q4 revenue $128.2M (+2% seq); EPS ex-items $0.19 (-14% seq); FY EPS +40%

## Summary
- Q4 revenue $128.2M (+2% sequentially); GAAP EPS $0.14, ex-items EPS $0.19 (down 14% seq).
- Q4 operating income ex-items $15.0M (12% margins); free cash flow $16.7M; debt cut $15M (8%).
- Full year revenue $510.0M (+4% YoY); operating income ex-items $61.2M (+36%); EPS ex-items $0.80 (+40%).
- Quarterly cash dividend $0.01/share, record Feb 12, payable Mar 4, 2024.
- Effective tax rate impacted by non-cash deferred tax adjustments from U.S. domestication.

## SEC filing metadata
- accession: 0000950170-24-009489
- form_type: 8-K
- ticker: CLB
- cik: 0001958086
- company_name: Core Laboratories Inc. /DE/
- filed_at: 2024-01-31T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1958086/000095017024009489/0000950170-24-009489-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1958086/000095017024009489/clb-20240131.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-009489
- JSON: https://secwatch.observer/filing/0000950170-24-009489.json
- Plain text: https://secwatch.observer/filing/0000950170-24-009489.txt

## Key facts
- Earnings Releases
  Core Laboratories Inc. /DE/ reported year ending December 31, 2023 results: revenue $510.0 million, EPS $0.86.
  - Period: year ending December 31, 2023
  - Revenue: $510.0 million
  - EPS: $0.86
  - Result: reported results
  source text: • FOURTH QUARTER FREE CASH FLOW OF $16.7 MILLION • FOURTH QUARTER DEBT REDUCED BY $15.0 MILLION OR OVER 8% • COMPANY ANNOUNCES Q1 2024 QUARTERLY DIVIDEND • FULL YEAR REVENUE OF $510.0 MILLION, UP 4% • FULL YEAR OPERATING INCOME OF $54.6 MILLION; EX-ITEMS, $61.2 MILLION, UP 36% • FULL YEAR GAAP EPS OF $0.86; EX-ITEMS, EPS OF $0.80, UP 40% HOUSTON (January 31, 2024) -
  evidence_url: https://www.sec.gov/Archives/edgar/data/1958086/000095017024009489/0000950170-24-009489-index.htm
- Earnings Releases
  Core Laboratories Inc. /DE/ reported fourth quarter of 2023 results: revenue $128,200,000, EPS $0.14.
  - Period: fourth quarter of 2023
  - Revenue: $128,200,000
  - EPS: $0.14
  - Result: reported results
  source text: 31, 2023. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS: • FOURTH QUARTER REVENUE OF $128.2 MILLION, UP 2% SEQUENTIALLY • FOURTH QUARTER OPERATING INCOME OF $14.6 MILLION; EX-ITEMS, $15.0 MILLION, DOWN 6% SEQUENTIALLY • FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% •
  evidence_url: https://www.sec.gov/Archives/edgar/data/1958086/000095017024009489/0000950170-24-009489-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.